Status:
COMPLETED
Indirect Magnetic Resonance Lymphangiography of the Head and Neck Region Using Conventional Gadolinium-based Contrast
Lead Sponsor:
Stanford University
Collaborating Sponsors:
McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.
Conditions:
Head and Neck Cancer
Head and Neck Cancers
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
To determine the ability of magnetic resonance lymphangiography using conventional gadolinium injected directly into the tumor site and PET scan in detecting microscopic nodal metastasis in patients w...
Eligibility Criteria
Inclusion
- Inclusion Criteria:Patients with newly diagnosed squamous cell carcinomas of the H\&N with primary tumor sites that are accessible to direct contrast injections
Exclusion
Key Trial Info
Start Date :
February 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2007
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00230295
Start Date
February 1 2003
End Date
November 1 2007
Last Update
July 27 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University School of Medicine
Stanford, California, United States, 94305